Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.

| 1436 | haematologica | 2008; 93(9) ic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991;78:1373-80. 2. Cwynarsky K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J, et al. Direct visualization of Cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001;97:1232-40. 3. Gratama JW, van Esser JWJ, Lamers CHJ, Tournay C, Löwenberg B, Bolhuis RL, et al. Tetramer-based quantification of Cytomegalovirus (CMV)-specific CD8 T lymphocytes in T-cell depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001;98:1358-64. 4. Özdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigenspecific CD8 T cells. Blood 2002;100:3690-7. 5. Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 2001;184:955-63. 6. Hebart H, Daginik S, Stevanovic S, Grigoleit U, Dobler A, Baur M, et al. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-γ enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 2002; 99: 3830-7. 7. Solano C, Muñoz I, Gutiérrez A, Farga A Prosper F García-Conde J, et al. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J Clin Microbiol 2001;39:3938-41. 8. Kern F, Faulhaber N, Frömmel C, Khatamzas E, Prösch S, Schönemann C, et al. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol 2000;30:167682. 9. Ohnishi M, Sakurai T, Heike Y, Yamazaki R, Kanda Y, Takue Y, et al. Evaluation of cytomegalovirus-specific Tcell reconstitution after various allogeneic haematopoietic stem cell transplantation using interferon-Á-enzymelinked immunospot and human leukocyte antigen tetramer assay with an immunodominant T-cell epitope. Br J Haematol 2005;131:472-9. 10. Lilleri D, Gerna G, Fornara C, Lozza L, Maccario R, Locatelli F. Prospective simultaneous quantification of human cytomegalovirus-specific CD4 and CD8 T-cell reconstitution in young recipients of allogeneic stem cell transplants. Blood 2006;108:1406-12. 11. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, et al. Broadly targeted human cytomegalovirus-specific CD4 and CD8 T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202:673-85. 12. Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, et al. Immune reconstitution to cytomegalovirus after allogeneic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 2003;102:3060-7.